SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
208 hedge funds and large institutions have $1.65B invested in Sage Therapeutics in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 61 increasing their positions, 71 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $1.65B → $1.65B (-$4.65M)
1% less funds holding
Funds holding: 210 → 208 (-2)
14% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 71
Holders
208
Holding in Top 10
2
Calls
$19.2M
Puts
$12.5M
Top Buyers
| 1 | +$48M | |
| 2 | +$31.7M | |
| 3 | +$26.4M | |
| 4 |
Goldman Sachs
New York
|
+$25.6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$15.6M |
Top Sellers
| 1 | -$72.5M | |
| 2 | -$28M | |
| 3 | -$16.3M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$9.69M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$8.7M |